Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Current Leases (2018 - 2026)

Champions Oncology (CSBR) has 8 years of Current Leases data on record, last reported at $1.5 million in Q2 2025.

  • For Q2 2025, Current Leases rose 10.02% year-over-year to $1.5 million; the TTM value through Apr 2025 reached $1.5 million, up 10.02%, while the annual FY2025 figure was $1.5 million, 10.02% up from the prior year.
  • Current Leases reached $1.5 million in Q2 2025 per CSBR's latest filing, up from $1.4 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.5 million in Q2 2025 and bottomed at $818000.0 in Q2 2021.
  • Average Current Leases over 5 years is $1.2 million, with a median of $1.3 million recorded in 2023.
  • Peak YoY movement for Current Leases: surged 554.4% in 2021, then rose 9.89% in 2025.
  • A 5-year view of Current Leases shows it stood at $818000.0 in 2021, then rose by 28.85% to $1.1 million in 2022, then rose by 20.97% to $1.3 million in 2023, then grew by 4.86% to $1.3 million in 2024, then grew by 10.02% to $1.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $1.5 million in Q2 2025, $1.4 million in Q1 2025, and $1.3 million in Q2 2024.